
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
LATEST POSTS
- 1
Partner of crime boss Steven Lyons arrested in Dubai - 2
Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas - 3
Vote In favor of Your Favored Kind Of Vegetable - 4
Vote in favor of Your #1 4K television: Lucidity and Drenching Matter - 5
Journalists killed by Israeli strike in southern Lebanon
Who was Haytham Ali Tabatabai, Hezbollah's military leader killed by Israel?
Civil rights leader Jesse Jackson hospitalized, family requests prayers
Vote In favor of Your Number one Cell phones
Step by step instructions to Protect Your Retirement with Senior Protection.
Where is Santa right now? NORAD tracks his 2025 Christmas Eve flight.
Survey: Canteen Cups With Great Warm Protection Impact
Two Endangered Bengal Tiger Cubs Die Days Apart at Zoo After Contracting Virus
How a rare drug made from scientists' blood saves babies from botulism
Poll: 62% of Americans would oppose U.S. military action in Greenland













